Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Consolidated Statements of Operations
Product revenue, net	$ 26,279	$ 23,125	$ 53,934	$ 45,022
Revenue from Contract with Customer, Product and Service	Product	Product	Product	Product
Cost of sales	$ 8,986	$ 10,826	$ 18,609	$ 20,267
Gross profit	17,293	12,299	35,325	24,755
Operating expenses
Research and development	1,710	4,475	2,774	6,127
Selling and marketing	10,560	9,660	20,662	18,957
General and administrative	8,018	7,953	15,340	16,169
Impairment expense	2,600		2,600	19,453
Amortization of intangible assets	1,198	1,505	2,395	3,042
Total operating expenses	24,086	23,593	43,771	63,748
Loss from operations	(6,793)	(11,294)	(8,446)	(38,993)
Other income (expense)
Other expense, net	(1,303)	(257)	(2,542)	(516)
Gain on derivative warrant liabilities	1,403		3,594
Total other income (expense)	100	(257)	1,052	(516)
Loss before income tax	(6,693)	(11,551)	(7,394)	(39,509)
Income tax benefit		(3)		(110)
Net loss	$ (6,693)	$ (11,548)	$ (7,394)	$ (39,399)
Weighted average number of common shares outstanding - basic (in shares)	3,110,304	1,320,623	2,817,979	1,300,151
Weighted average number of common shares outstanding - diluted (in shares)	3,110,304	1,320,623	2,817,979	1,300,151
Basic net loss per common share (in dollars per share)	$ (2.15)	$ (8.74)	$ (2.62)	$ (30.30)
Diluted net loss per common share (in dollars per share)	$ (2.15)	$ (8.74)	$ (2.62)	$ (30.30)